MarketsStocksBACPHAR
BA

Bacil Pharma Ltd.

NSE: BACPHARBSE: 524516Healthcare
Download Research Report7-page PDF
48.50
-1.80%
NSE · auto-updates while market open
Mkt Cap
₹69 Cr
P / E
51.4
P / B
2.8
ROE
5.3%
52W High
₹61.80
52W Low
₹26.69
Key Metrics
Market Cap
₹69 Cr
P / E
51.36
P / B
2.77
EV / EBITDA
-
ROCE
3.9%
ROE
5.3%
Debt / Equity
0.00
Book Value
₹17.76
EPS
₹1.11
Div Yield
0.0%
Face Value
-
Promoter Holding
-
Revenue · ₹ Cr
0
FY22
0
FY23
0
FY24
1
FY25
1
FY26
Net Profit · ₹ Cr
0
2
-4
0
0
FY22FY23FY24FY25FY26
EPS · ₹ per share
₹0.6
₹1.1
₹-6.5
₹-0.2
₹-0.1
FY22FY23FY24FY25FY26
Q1 2026 snapshot
Sales
₹0 Cr
Operating profit
-
OPM
-
Net profit
₹1 Cr
EPS
₹0.44
Scorecard · 7 axes
Quality
Avg
56/100
Valuation
Weak
51.4×
Growth
Strong
+57.6%
Profitability
Bad
4.6%
Performance
Avg
+18.9%
Entry Point
Good
78%
Red Flags
Strong
0 flags
Shareholding Pattern
100.0%Public
Public100.0%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue00.0910.050.060.11
Net Profit-0.0620.0160.6690.0140.0390.622
NPM %-17.2%66.9%27.6%65.3%565.1%
AlertPre-trade